Skip to main content
. 2026 Jun 20;18(12):2002. doi: 10.3390/nu18122002
ADI Acceptable daily intake
BMI Body mass index
CPIR Cephalic phase insulin response
EFSA European Food Safety Authority
FDA Food and Drug Administration
GLP-1 Glucagon-like peptide 1
GRAS Generally recognized as safe
HbA1c Hemoglobin A1C
HDL-c High-density lipoprotein cholesterol
IR Insulin resistance
JECFA Joint FAO/WHO Expert Committee on Food Additives
LDL-c Low-density lipoprotein cholesterol
OGTT Oral glucose tolerance test
ND No statistical differences detected
NGO Non-governmental organization
NNS(s) Non-nutritive sweetener(s)
PYY Peptide YY
RCT(s) Randomized controlled trial(s)
Reb Rebaudioside
SCFAs Short-chain fatty acids
TC Total cholesterol
TG Triglyceride
VLDL-c Very-low-density lipoprotein-cholesterol
WHO-NUGAG World Health Organization Nutrition Guidance Expert Advisory Committee